The young student, Nike von Borcke, asked us if she could interview us for the school project "Youth and Economy" of the German newspaper Frankfurter Allgemeine Zeitung (F.A.Z.). No question. That's where we're in. See here what she wrote about us.
Green clothes, concentrated faces, an operating table in the middle of the room. On top of it a patient, body covered with cloths. Several people are working bent over the patient. On a side table the operating equipment is placed. The small cut in the patient's head is hardly visible. The surgeon grasps an instrument and guides it through a trocar, which is placed in a small perforation in the skull. Gradually, other instruments are used. The surgeon's aim is to destroy a brain tumor. In this operating theatre a rare surgical technique is performed. Usually, brain tumors are resected openly after the removal of a large piece of the skull. However, the Endoscopic Neurosurgical Pen (ENP) from Söring GmbH in Quickborn, Germany, allows removing certain types of brain tumors in a minimally invasive way. "Apart from our ENP, there is no other ultrasonic instrument that can be guided through such a small opening in the head," says Carina Tooren, Product Manager Neurosurgery at Söring. "The instrument shall support the surgeon to remove the tumor as much as possible without damaging healthy tissue. Compared to open surgery, the small access is considered gentler on the patient. Our ENP instrument offers physicians new surgical options, especially for small and medium-sized tumors located in the cerebral ventricles.” Carlos Jaime Yepes Sanchez, neurosurgeon at the Clínica Las Américas hospital in Medellín, Colombia, explains, "the ENP is particularly fast in removing tumors and the surgeon has better control over bleedings."
In contrast to the ENP, products for open surgery, such as the LEVICS Micro instrument, are the gold standard and of course Söring faces competitors in this field. "Nevertheless, we are still one of the global players in ultrasonic surgery," explains Florian Neumann, Technical Director at Söring. There are only three major competitors, which are all American.
Founded for cancer treatment
Söring was founded in 1985 by Holger Söring and is still a family business today. The current managing director, Anna Söring-Neumann, is the daughter of the founder, who died in 2012. The company has 120 employees. "Holger Söring developed the first product, a generator for ultrasonic instruments, in his garage," reports Anita Urban, Marketing Manager at Söring. "One of his parents was affected by cancer and at that time there was no system available in Europe to remove tumors via ultrasonic surgery. That was the motivation for developing his first product. He simply wanted to help." Then in 1989 it was time for the breakthrough: An ultrasonic generator developed by Söring was used in a very special operation. "At that time in Malaysia, conjoined twins who had grown together at the liver were separated for the first time by ultrasonic surgery. This is how we became famous in the industry." Today, Söring also offers a product for minimally invasive liver surgery. "Our LUD is the world's longest and thinnest laparoscopic ultrasonic dissector for liver surgery," says Urban. Further business areas are spine surgery and Ultrasonic-Assisted Wound Debridement (UAW).
Even today, Söring is active worldwide. The distribution network extends to more than 90 countries. In addition to its headquarters in Quickborn, the company is also represented in Colombia, Russia and the USA. All products are developed and manufactured in Quickborn and in production facilities in the immediate vicinity. "The fact that our products are 'Made in Germany' is regarded as a seal of quality," explains Urban.
Research activities pave the way for the future
In order to be well prepared for the future, the company repeatedly participates in research projects. Currenly, Söring is investigating how brain tumors can be automatically detected and better removed, since one of the main challenges in neurosurgey is to maintain healthy brain tissue and larger blood vessels. In this three-year project called "UltraLas" the LEVICS Micro instrument plays an important role. "Our goal is to minimize the risk for patients and increase their expectancy and quality of life. Their well-being is our motivitation. Söring has been working with this drive since the company was founded," concludes Tooren.